To explore the value of contrast-enhanced CT texture analysis in predicting isocitrate dehydrogenase (IDH) mutation status of intrahepatic cholangiocarcinomas (ICCs). The gene discussed is IDH1; the disease is intrahepatic cholangiocarcinoma.